David Wright

Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout

Peter E. Lipsky, Leonard H. Calabrese, Arthur Kavanaugh et al. · Arthritis Research & Therapy · 2014 · 261 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +15

Results of a Randomized Trial of Chlorambucil Versus Fludarabine for Patients With Untreated Waldenström Macroglobulinemia, Marginal Zone Lymphoma, or Lymphoplasmacytic Lymphoma

Véronique Leblond, S.A. Johnson, Sylvie Chevret et al. · Journal of Clinical Oncology · 2012 · 152 citations

Medicine, Oncology, Pharmacotherapy +15

Phase 2, randomized, double‐blind study of pracinostat in combination with azacitidine in patients with untreated, higher‐risk myelodysplastic syndromes

Guillermo Garcia‐Manero, Guillermo Montalban‐Bravo, Jesús G. Berdeja et al. · Cancer · 2017 · 105 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Nasopharyngeal and Cervical Chordoma—Some Aspects of their Development and Treatment

David Wright · The Journal of Laryngology & Otology · 1967 · 82 citations

Medicine, Oncology, Otolaryngology +12

The VVSymQ® instrument: Use of a new patient-reported outcome measure for assessment of varicose vein symptoms

Jean Paty, Diane M. Turner‐Bowker, Celeste A. Elash et al. · Phlebology The Journal of Venous Disease · 2015 · 62 citations · Full text

Pharmacy, Internal Medicine, Electronic Health Records +16